1. Low Serum Hepatitis B Surface Antigen Level Predicts Compensated Cirrhosis Caused by Chronic Hepatitis B in HBeAg Positive Patients in East China
   Wen Jia et al, 2015, Hepat Mon CrossRef
2. Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase
   Da-Wu Zeng et al, 2016, WJG CrossRef
3. Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection
   Da-Wu Zeng et al, 2016, WJG CrossRef
4. A critical role of hepatitis B virus polymerase in cirrhosis, hepatocellular carcinoma, and steatosis
   Hea-Jong Chung et al, 2017, FEBS Open Bio CrossRef
5. Reflection and observation: cell-based screening failing to detect HBV in HUMSCs derived from HBV-infected mothers underscores the importance of more stringent donor eligibility to reduce risk of transmission of infectious diseases for stem cell-based medical products
   Wei Liu et al, 2018, Stem Cell Res Ther CrossRef
6. Serum alkaline phosphatase levels as a simple and useful test in screening for significant fibrosis in treatment-naive patients with hepatitis B e-antigen negative chronic hepatitis B
   Jianhua Hu et al, 2019, European Journal of Gastroenterology & Hepatology CrossRef
7. Comparative metabolomics unveils molecular changes and metabolic networks of syringin against hepatitis B mice by untargeted mass spectrometry
   Yi-chang Jiang et al, 2020, RSC Adv. CrossRef
8. Clinical characteristics and association analysis of persistent low‑level HBsAg expression in a physical examination population with HBV infection
   Yuzhu Dai et al, 2019, Exp Ther Med CrossRef
9. Hepatitis B infection and intrahepatic cholestasis of pregnancy
   Ruoan Jiang et al, 2020 CrossRef
10. Quantitative HBcrAg and HBcAb versus HBsAg and HBV DNA in predicting liver fibrosis levels of chronic hepatitis B patients
    Zhan-qing Zhang et al, 2020, Gastroenterología y Hepatología CrossRef
11. A non-invasive model for predicting liver fibrosis in HBeAg-positive patients with normal or slightly elevated alanine aminotransferase
    Ling Li et al, 2021 CrossRef
12. Liver Fibrosis in the Natural Course of Chronic Hepatitis B Viral Infection: A Systematic Review with Meta-Analysis
    Mei-Hong Lin et al, 2021, Dig Dis Sci CrossRef
13. Discovery of New Hepatitis B Virus Capsid Assembly Modulators by an Optimal High-Throughput Cell-Based Assay
    Yameng Pei et al, 2019, ACS Infect. Dis. CrossRef
14. Serum qAnti‐HBc combined with ALT and HBsAg predicts significant hepatic inflammation in HBeAg‐positive immune active patients
    Xiaomei Wang et al, 2022, J of Gastro and Hepatol CrossRef
15. A Predictive Model to Evaluate the HbeAg Positivity of Chronic Hepatitis B Virus Patients in Clinics: A Cross-Sectional Study
    Ning Wang et al, 2022, Medicina CrossRef
16. Nomogram for evaluating obvious liver inflammation in treatment-naïve HBeAg positive chronic hepatitis B virus infection patients with normal ALT
    Lu Zhang et al, 2023, Virulence CrossRef
17. A nomogram based on HBeAg, AST, and age to predict non-minimal liver inflammation in CHB patients with ALT <80 U/L
    Lu Zhang et al, 2023, Front. Immunol. CrossRef
18. HbsAg seviyesinin HBV DNA ve karaciğer fibrozisi ile ilişkisi
    Ahmet Ramiz BAYKAN et al, 2023 CrossRef
19. Baseline albumin-bilirubin score: a predictor for HBeAg clearance in patients with chronic hepatitis B after nucleos(t)ide analogue treatment
    Yao Zhang et al, 2023 CrossRef
20. Association of Hepatitis B Surface Antigen Levels With Long‐Term Complications in Chronic Hepatitis B Virus Infection: A Systematic Literature Review
    Anadi Mahajan et al, 2024, Journal of Viral Hepatitis CrossRef
21. Non-invasive Diagnostic Indicators and Antiviral Treatment Efficacy in CHB Patients with Different Liver Histopathological Degrees
    Feng Chen et al, 2024, Hepat Mon CrossRef
22. Postpartum hepatitis flares in mothers with chronic hepatitis B infection
    Shi OuYang et al, 2023 CrossRef
23. Analysing Liver Histology in Relation to Elevated HBV DNA Levels in Immuno-Tolerant Phase of Chronic Hepatitis B Viral Infection Patients
    Nurudeen Muhammad et al, 2024, CMR CrossRef